1. Home
  2. AZTA vs AMRX Comparison

AZTA vs AMRX Comparison

Compare AZTA & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • AMRX
  • Stock Information
  • Founded
  • AZTA 1978
  • AMRX 2002
  • Country
  • AZTA United States
  • AMRX United States
  • Employees
  • AZTA N/A
  • AMRX N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AZTA Technology
  • AMRX Health Care
  • Exchange
  • AZTA Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • AZTA 2.2B
  • AMRX 2.7B
  • IPO Year
  • AZTA 1995
  • AMRX N/A
  • Fundamental
  • Price
  • AZTA $41.51
  • AMRX $8.47
  • Analyst Decision
  • AZTA Buy
  • AMRX Strong Buy
  • Analyst Count
  • AZTA 5
  • AMRX 5
  • Target Price
  • AZTA $63.60
  • AMRX $10.00
  • AVG Volume (30 Days)
  • AZTA 533.4K
  • AMRX 1.1M
  • Earning Date
  • AZTA 11-12-2024
  • AMRX 11-08-2024
  • Dividend Yield
  • AZTA N/A
  • AMRX N/A
  • EPS Growth
  • AZTA N/A
  • AMRX N/A
  • EPS
  • AZTA N/A
  • AMRX N/A
  • Revenue
  • AZTA $656,323,000.00
  • AMRX $2,680,420,000.00
  • Revenue This Year
  • AZTA $0.52
  • AMRX $17.56
  • Revenue Next Year
  • AZTA $6.49
  • AMRX $3.23
  • P/E Ratio
  • AZTA N/A
  • AMRX N/A
  • Revenue Growth
  • AZTA N/A
  • AMRX 12.32
  • 52 Week Low
  • AZTA $40.24
  • AMRX $4.16
  • 52 Week High
  • AZTA $69.16
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 38.58
  • AMRX 45.78
  • Support Level
  • AZTA $44.72
  • AMRX $7.52
  • Resistance Level
  • AZTA $50.81
  • AMRX $9.48
  • Average True Range (ATR)
  • AZTA 2.24
  • AMRX 0.35
  • MACD
  • AZTA 0.04
  • AMRX 0.02
  • Stochastic Oscillator
  • AZTA 5.78
  • AMRX 48.59

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: